Sign In

Consumer Health in
Egypt

Country Report

US$2,650
Add to cart

Executive Summary

Oct 2019
Demand continues to increase in consumer health despite high inflation

2019 saw further increases in value sales across most consumer health categories despite the strong unit price increases that were seen, the result of high inflation. Egypt is still recovering from the severe devaluation of the Egyptian pound against major global currencies in late 2017.

Strong self-medication culture support sales in all OTC categories

2019 saw positive growth recorded in OTC consumer health, with all categories registering an increase in demand over the course of the year. The main reason for this positive performance is the strongest self-medication culture which remains a major feature of the Egyptian healthcare scene.

Stability in the competitive environment the result of regulatory burdens

Apart from the change of NBO for GlaxoSmithKline’s brands to subsidiary GSK Consumer Health, few changes were seen in the competitive environment in consumer health in 2019. The main reason for this lack of dynamism in the industry is the rigid regulatory environment imposed by the Ministry of Health.

Strict regulations limit product distribution to chemists/pharmacies

The sale of consumer health products in Egypt is strictly regulated by the Ministry of Health and the distribution of almost all products across industry is confined to chemists/pharmacies. For this reason, retail pharmacists have major influence over the purchasing decisions of consumers and they are typically looked to for health advice.

Further sales growth anticipated over the forecast period

Over the forecast period, consumer health is expected to continue registering as it of sales growth as demand continues to recover from the effects of the economic crisis. In addition, strong population growth, notably due to the country’s high birth rate is set to expand the consumer base.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports
Frequently asked questions Our Definitions

Consumer Health in Egypt

Samples: (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Egypt with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Egypt, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Egypt for free:

The Consumer Health in Egypt market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Egypt?
  • What are the major brands in Egypt?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Consumer Health in Egypt

EXECUTIVE SUMMARY

Demand continues to increase in consumer health despite high inflation
Strong self-medication culture support sales in all OTC categories
Stability in the competitive environment the result of regulatory burdens
Strict regulations limit product distribution to chemists/pharmacies
Further sales growth anticipated over the forecast period

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 2 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 3 Sales of Consumer Health by Category: Value 2014-2019
Table 4 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 5 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 6 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 7 Distribution of Consumer Health by Format: % Value 2014-2019
Table 8 Distribution of Consumer Health by Format and Category: % Value 2019
Table 9 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources

Analgesics in Egypt

HEADLINES

PROSPECTS

Analgesics continues to benefit from Egypt’s strong self-medication culture
Aspirin and ibuprofen register slower demand as all categories record strong growth
Strong growth due to population growth and consistent demand throughout the year

COMPETITIVE LANDSCAPE

GSK’s range of strong brands ensures the company’s ongoing leadership
Brufen by Abbott Laboratories is still the leading brand in analgesics
Rising demand for diclofenac benefits Novartis

CATEGORY DATA

Table 11 Sales of Analgesics by Category: Value 2014-2019
Table 12 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 13 NBO Company Shares of Analgesics: % Value 2015-2019
Table 14 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 15 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024

Cough, Cold and Allergy (Hay Fever) Remedies in Egypt

HEADLINES

PROSPECTS

Category sales continue to be supported by strong preference for self-medication
Demand remains highly seasonal in all categories
Inconsistent supply products and supplements stock shortages hit sales

COMPETITIVE LANDSCAPE

GSK Consumer Healthcare enters category as the strong leading player
Seasonality of demand hits profitability, suppressing sales growth.
Restrictions on marketing lead players to focus promotional efforts on retail outlets

CATEGORY DATA

Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2014-2019
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2014-2019
Table 19 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2019
Table 20 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2019
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024

Dermatologicals in Egypt

HEADLINES

PROSPECTS

Prevalence of dermatological conditions remains high due to low hygiene standards
High birth rate continues to support strong growth in nappy (diaper) rash treatments
Unit price stability returns to the category, supporting higher demand

COMPETITIVE LANDSCAPE

GSK Consumer Healthcare leads sales with a wide portfolio of trusted brands
Local brands benefit from low prices and less stringent consumer expectations
No new launches seen in the category due to stringent regulations and low margins

CATEGORY DATA

Table 23 Sales of Dermatologicals by Category: Value 2014-2019
Table 24 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 25 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 26 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 27 LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
Table 28 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 29 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Dietary Supplements in Egypt

HEADLINES

PROSPECTS

Wide variety of affordable products supports sales growth
Minerals remains the largest non-herbal/traditional dietary supplements category
Dietary deficiencies underpin strong demand for minerals

COMPETITIVE LANDSCAPE

Local player Eva Pharma leads a highly fragmented category, ahead of GSK
High levels of fragmentation likely to remain a feature of dietary supplements
Difficult and lengthy product registration process discourages innovation

CATEGORY DATA

Table 30 Sales of Dietary Supplements by Category: Value 2014-2019
Table 31 Sales of Dietary Supplements by Category: % Value Growth 2014-2019
Table 32 Sales of Dietary Supplements by Positioning: % Value 2014-2019
Table 33 NBO Company Shares of Dietary Supplements: % Value 2015-2019
Table 34 LBN Brand Shares of Dietary Supplements: % Value 2016-2019
Table 35 Forecast Sales of Dietary Supplements by Category: Value 2019-2024
Table 36 Forecast Sales of Dietary Supplements by Category: % Value Growth 2019-2024

Digestive Remedies in Egypt

HEADLINES

PROSPECTS

The general preference for self-medication continues to support sales growth
Food poisoning a common source of sales for digestive remedies
Sales continue to be dominated by indigestion and heartburn remedies

COMPETITIVE LANDSCAPE

Pharco overtakes GSK Consumer Healthcare to assume category leadership
Low prices remain important in a high-volume category of frequently used products
High demand among low-income consumers supports sales of cheaper brands and generics

CATEGORY DATA

Table 37 Sales of Digestive Remedies by Category: Value 2014-2019
Table 38 Sales of Digestive Remedies by Category: % Value Growth 2014-2019
Table 39 NBO Company Shares of Digestive Remedies: % Value 2015-2019
Table 40 LBN Brand Shares of Digestive Remedies: % Value 2016-2019
Table 41 Forecast Sales of Digestive Remedies by Category: Value 2019-2024
Table 42 Forecast Sales of Digestive Remedies by Category: % Value Growth 2019-2024

Eye Care in Egypt

HEADLINES

PROSPECTS

Severe air pollution continues to support demand for eye care products
Allergy eye care dominates volume sales as standard eye care dominates value sales
Drops remains the dominant format in eye care

COMPETITIVE LANDSCAPE

Kahira is the leading name in eye care as its brands continue to attract consumers
Low average unit price supports overall sales of eye care
Limited innovation the result of restrictive government policies

CATEGORY DATA

Table 43 Sales of Eye Care by Category: Value 2014-2019
Table 44 Sales of Eye Care by Category: % Value Growth 2014-2019
Table 45 NBO Company Shares of Eye Care: % Value 2015-2019
Table 46 LBN Brand Shares of Eye Care: % Value 2016-2019
Table 47 Forecast Sales of Eye Care by Category: Value 2019-2024
Table 48 Forecast Sales of Eye Care by Category: % Value Growth 2019-2024

Herbal/Traditional Products in Egypt

HEADLINES

PROSPECTS

Widespread consumer acceptance of herbal remedies continues to support sales
Herbal/traditional products faces strong competition from unpackaged alternatives
Herbal/traditional paediatric dietary supplements registers dynamic growth

COMPETITIVE LANDSCAPE

Competitive environment characterised by high levels of fragmentation
Strict regulation and price controls continue to stifle innovation and new product development

CATEGORY DATA

Table 49 Sales of Herbal/Traditional Products by Category: Value 2014-2019
Table 50 Sales of Herbal/Traditional Products by Category: % Value Growth 2014-2019
Table 51 NBO Company Shares of Herbal/Traditional Products: % Value 2015-2019
Table 52 LBN Brand Shares of Herbal/Traditional Products: % Value 2016-2019
Table 53 Forecast Sales of Herbal/Traditional Products by Category: Value 2019-2024
Table 54 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024

NRT Smoking Cessation Aids in Egypt

PROSPECTS

NRT smoking cessation aids remains a marginal category with no growth prospects

Paediatric Consumer Health in Egypt

HEADLINES

PROSPECTS

Lack of paediatric consumer health products continues to limit category development
Paediatric analgesics and paediatric digestive remedies remain dominant
The development of paediatric consumer health held back by strict regulation

COMPETITIVE LANDSCAPE

Local players remain dominant in paediatric consumer health
Prohibition on advertising and marketing stifles dynamism in paediatric consumer health

CATEGORY DATA

Table 55 Sales of Paediatric Consumer Health by Category: Value 2014-2019
Table 56 Sales of Paediatric Consumer Health by Category: % Value Growth 2014-2019
Table 57 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2019
Table 58 NBO Company Shares of Paediatric Consumer Health: % Value 2015-2019
Table 59 LBN Brand Shares of Paediatric Consumer Health: % Value 2016-2019
Table 60 Forecast Sales of Paediatric Consumer Health by Category: Value 2019-2024
Table 61 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024

Sleep Aids in Egypt

HEADLINES

PROSPECTS

Sales of sleep aids likely to remain low due to limited consumer awareness
To boost surrounding the use of sleep aids continues to suppress sales
Sleep aids has strong growth potential as insomnia becomes increasingly common

COMPETITIVE LANDSCAPE

Medizen and Sigma Pharmaceutical Industries remain in the leading positions
Local companies remain prominent among the leading names in sleep aids
Complex and highly regulated registration process discourages new launches

CATEGORY DATA

Table 62 Sales of Sleep Aids: Value 2014-2019
Table 63 Sales of Sleep Aids: % Value Growth 2014-2019
Table 64 NBO Company Shares of Sleep Aids: % Value 2015-2019
Table 65 LBN Brand Shares of Sleep Aids: % Value 2016-2019
Table 66 Forecast Sales of Sleep Aids: Value 2019-2024
Table 67 Forecast Sales of Sleep Aids: % Value Growth 2019-2024

Sports Nutrition in Egypt

HEADLINES

PROSPECTS

Egyptians take to sport and fitness and ever greater numbers
Unit prices continue to rise due to the preponderance of imported products
Lack of effective regulation continues to present challenges and opportunities

COMPETITIVE LANDSCAPE

No changes seen in the competitive environment as Optimum Nutrition leads
Shifting regulations and inconsistent application of the law remain major barriers
Local products sees the opportunity to gain ground as importers face issues

CATEGORY DATA

Table 68 Sales of Sports Nutrition by Category: Value 2014-2019
Table 69 Sales of Sports Nutrition by Category: % Value Growth 2014-2019
Table 70 NBO Company Shares of Sports Nutrition: % Value 2015-2019
Table 71 LBN Brand Shares of Sports Nutrition: % Value 2016-2019
Table 72 Forecast Sales of Sports Nutrition by Category: Value 2019-2024
Table 73 Forecast Sales of Sports Nutrition by Category: % Value Growth 2019-2024

Vitamins in Egypt

HEADLINES

PROSPECTS

The inability of companies to market and advertise their products hinders growth
Doctors are not normally consulted before Egyptians purchase vitamins
Multivitamins remains the dominant vitamins category due to the value it represents

COMPETITIVE LANDSCAPE

Local companies remain the major players in vitamins
Paediatric vitamins remains a niche category with considerable room for growth
The prohibition on advertising ensures a highly stable competitive environment

CATEGORY DATA

Table 74 Sales of Vitamins by Category: Value 2014-2019
Table 75 Sales of Vitamins by Category: % Value Growth 2014-2019
Table 76 Sales of Multivitamins by Positioning: % Value 2014-2019
Table 77 NBO Company Shares of Vitamins: % Value 2015-2019
Table 78 LBN Brand Shares of Vitamins: % Value 2016-2019
Table 79 Forecast Sales of Vitamins by Category: Value 2019-2024
Table 80 Forecast Sales of Vitamins by Category: % Value Growth 2019-2024

Weight Management and Wellbeing in Egypt

HEADLINES

PROSPECTS

Unhealthy lifestyles and high-fat diets remain common among the population
The preference for traditional and natural weight loss remedies continues to suppress demand
Cultural preference for plump, curvy woman to continue suppressing demand

COMPETITIVE LANDSCAPE

Eva Pharma remains the strong leader in weight management and wellbeing
The ban on marketing and advertising results in lack of dynamism in the category

CATEGORY DATA

Table 81 Sales of Weight Management and Wellbeing by Category: Value 2014-2019
Table 82 Sales of Weight Management and Wellbeing by Category: % Value Growth 2014-2019
Table 83 NBO Company Shares of Weight Management and Wellbeing: % Value 2015-2019
Table 84 LBN Brand Shares of Weight Management and Wellbeing: % Value 2016-2019
Table 85 Forecast Sales of Weight Management and Wellbeing by Category: Value 2019-2024
Table 86 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024

Wound Care in Egypt

HEADLINES

PROSPECTS

Wound care continues to underperform
Wide distribution contributes to strong growth in wound care
The preference for traditional home-made alternatives to remain a drag on growth

COMPETITIVE LANDSCAPE

Pharmaplast dominates sales in a highly consolidated category
Alexandria Co for Pharmaceuticals & Chemical Industries the only serious challenger to Pharmaplast
Low levels of brand loyalty defines the competitive environment in wound care

CATEGORY DATA

Table 87 Sales of Wound Care by Category: Value 2014-2019
Table 88 Sales of Wound Care by Category: % Value Growth 2014-2019
Table 89 NBO Company Shares of Wound Care: % Value 2015-2019
Table 90 LBN Brand Shares of Wound Care: % Value 2016-2019
Table 91 Forecast Sales of Wound Care by Category: Value 2019-2024
Table 92 Forecast Sales of Wound Care by Category: % Value Growth 2019-2024